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This case representsthe ﬁrst report on the isolation
of a difﬁcult-to-identify clinical isolate of Mycobac-
terium elephantis from Asia.
Case presentation
A 72-year-old woman was admitted to hospital
because of chronic respiratory disease for approxi-
mately 2 months. Her major symptoms included
dry cough and nocturnal fever (to 38˚C). Her out-
patient record indicated that she was prescribed
amoxicillin by her general practitioner but no
improvement was obtained. She had no history of
infection with mycobacteria or contact with an ele-
phant. Results of physical examination were unre-
markable. The patient’s tuberculin test was
negative. Routine laboratory testing on admission
revealed an elevated C-reactive protein (CRP) of
34 mg/L, and an erythrocyte sedimentation rate
of 45 mm/hr. The chest X-ray examination
showed a diffuse shadow in the right apex sugges-
tive of pulmonary tuberculosis. The initial micro-
biological examination of bronchial lavage by the
hospital laboratory revealed the presence of small
coccobacillary acid-fast organisms. The bronchial
lavage specimen was cultured on Lo ¨wenstein-
Jensen medium for mycobacterial isolation. Since
the growth of the isolate on Lo ¨wenstein-Jensen
medium was slower than that for the majority of
rapidly growing mycobacteria, and due to apical
pulmonary lesions the patient was misdiagnosed
as having tuberculosis and entered into the TB Reg-
ister. After one month of antituberculosis therapy,
the patient discontinued treatment due to extreme
weakness and severe abdominal pain. Meanwhile
the isolate was referred to our laboratory for
deﬁnitive identiﬁcation. Further investigation on
repeated specimens revealed that the infecting
micro-organism was a rapidly growing mycobac-
teria. The patient’s treatment was changed from
the antituberculosis regimen to a combination
therapy consisting of amikacin and ciproﬂoxacin.
After two months of treatment she recovered and
has remained well ever since.
The conventional identiﬁcation and drug sus-
ceptibility of the Iranian isolate, namely, ‘M202’
was achieved according to the standard pro-
cedures described previously.
1,2 The conclusive
identiﬁcation included molecular testing, i.e. the
PCR restriction fragment length polymorphism
analysis (PRA algorithm) of the hsp65
3 and direct
sequencing analysis of almost full length of 16S
rDNA
4 and 16S–23S internal transcribed spacer
(ITS)
5 as well as partial sequencing of hsp65
3 and
rpoB genes.
6 The GenBank accession numbers of
M. elephantis determined in this work are as
follow: GU142921, HM229788-90 for 16S rDNA,
rpoB, hsp65 and ITS genes, respectively.
Based on the phenotypic characteristics, M202
wasa scotochromogenicrapidlygrowingmycobac-
terial species which grew at 37˚C and 45˚C as well
as on Lo ¨wenstein-Jensen medium with 5% NaCl. It
waspositive for the key biochemical tests including
catalase, nitrate, urease, tween hydrolysis and tell-
urite reduction tests. It was resistant to rifampicin
but susceptible to amikacin, clarithromycin, cipro-
ﬂoxacin, ethambutol, isoniazid, doxicyclin, strepto-
mycin, cefoxitin, sulfamethoxazol and imipenem.
The main microbiological traits of the Iranian
isolate resembled those of the human clinical
strains of M. elephantis characterized by Turenne
et al.
7 and Tortoli et al.
8
In PRA method the isolate exhibited a unique
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1published patterns
3 as well as from those in our
in-house library.
The 16S rDNA, rpoB and hsp65 gene sequences
of the isolate showed 100%, 98.7% and 96.2% simi-
larities with those of the validly published refer-
ence strains of M. elephantis, respectively. The
hypervariable signature sequences of 16S rDNA
of M202 were identical to those of the type strain
of M. elephantis (Figure 1). The ITS sequence of
M202 was unique compared with those of other
validly published mycobacteria.
Discussion
Further to the phenotypic features, all molecular
tests used in the current study provided the evi-
dence that the Iranian isolate belongs to
M. elephantis species.
M. elephantis is a rapidly growing mycobacteria
ﬁrst isolated from a lung abscess in a Sri Lankan
elephant that died from chronic respiratory
disease.
4 Human isolation of this species has
been reported from the developed countries
including Canadian, Italian and Belgian patient
specimens.
7–9 It belongs to a group of clinical
isolates of mycobacteria which has been evaluated
as difﬁcult-to-identify organisms by Springer
et al.
10
Our case represents the ﬁrst report of isolation
of M. elephantis from the human clinical specimen
in a developing country. The elderly patient had
no apparent underlying diseases. However, the
risk factors for mycobacterial infection could not
completely be excluded in the patient due to age.
The etiologic role of the isolate M202 might be
inferred from the fact that acid fast bacilli were
microscopically observed in two different bron-
chial lavage specimens of the patient. Further-
more, the isolate was recovered from the pure
culture. Also, no such isolate was made in our lab-
oratory in the past and during the same period of
time. As for 15 previously reported clinical
strains,
7–9 the clinical relevance of M. elephantis
remains difﬁcult to ascertain since the isolate is
very rare and hard to identify. Increased aware-
ness of this species might help to distinct this
species from closely related mycobacteria to
more exactly determine the role of M. elephantis
in human infection.
In conclusion, this case re-afﬁrmsthe fact stated
by Tortoli et al.
8 that the environment is the most
probable reservoir of M. elephantis for either
human or animal infections. It is not limited to a
certain geographic area. Furthermore, the key
molecular markers when combined with the
major microbiological traits provide a conclusive
evidence for identiﬁcation of the rare clinicallysig-
niﬁcant non-tuberculous mycobacteria.
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